Finding better ways to screen high-risk Black women for lung cancer
Evaluating the Feasibility of Lung Cancer Screening in High-Risk Black Women
['FUNDING_OTHER'] · MASSACHUSETTS GENERAL HOSPITAL · NIH-10893382
This study is looking at how we can better screen Black women who are at high risk for lung cancer, even if they don't fit the usual guidelines, by using special low-dose scans to catch the disease earlier and help save lives.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MASSACHUSETTS GENERAL HOSPITAL (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10893382 on ClinicalTrials.gov |
What this research studies
This research investigates how to improve lung cancer screening for Black women who are at high risk but may not meet current screening guidelines. It focuses on using low-dose computed tomography (LDCT) scans, which have been shown to detect lung cancer earlier and reduce mortality rates. The study aims to identify more women who could benefit from screening by evaluating their risk factors and health history. By addressing the gaps in eligibility criteria, the research seeks to enhance early detection of lung cancer and related cardiovascular diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black women who are considered high-risk for lung cancer but do not currently qualify for screening under existing guidelines.
Not a fit: Patients who are not at high risk for lung cancer or who do not identify as Black women may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection of lung cancer in high-risk Black women, potentially saving lives and reducing healthcare costs.
How similar studies have performed: Previous studies have shown that LDCT screening can significantly improve early detection of lung cancer, indicating a promising approach for this research.
Where this research is happening
BOSTON, UNITED STATES
- MASSACHUSETTS GENERAL HOSPITAL — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: YANG, CHI-FU — MASSACHUSETTS GENERAL HOSPITAL
- Study coordinator: YANG, CHI-FU
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.